Status:
TERMINATED
His Bundle Pacing Versus Right Ventricular Pacing
Lead Sponsor:
University Hospital, Geneva
Conditions:
Pacing-Induced Cardiomyopathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will randomize cross-over periods of 6 months of right ventricular pacing and His bundle pacing in patients with baseline left ventricular ejection fraction (LVEF)\>40%. The primary outcome...
Detailed Description
Monocentric, randomized, double-blind comparative crossover clinical study. Patients with a standard pacing indication with \>20% ventricular pacing, with a baseline LVEF \>40%, implanted with a func...
Eligibility Criteria
Inclusion
- Baseline LVEF\>40%
- Standard pacing indication with \>20% VP
- Functional His bundle lead with confirmed His capture
- Functional right ventricular lead with myocardial capture
Exclusion
- Unable to sign an informed consent form
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 4 2025
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04672408
Start Date
August 1 2021
End Date
April 4 2025
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Geneva
Geneva, Canton of Geneva, Switzerland, 1211